Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion type Assertion NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_head.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion description "[Inherited mutations in the tumor suppressor BRCA2 are predisposed to pancreatic adenocarcinomas, which carry activating mutations in the KRAS oncogene in more than 95% of cases, as well as frequent TP53 inactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_provenance.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion evidence source_evidence_literature NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_provenance.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion SIO_000772 21289082 NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_provenance.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion wasDerivedFrom befree-2016 NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_provenance.
- NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_assertion wasGeneratedBy ECO_0000203 NP869763.RAjMuHc39OMwIOKt4RLN_v8sTDVL-SNo63KGOz-fnk6hg130_provenance.